1482O A phase III study comparing methotrexate (M), adriamycin (A) and cisplatin (P) with MAP + ifosfamide (MAP + IF) for the treatment of osteosarcoma: JCOG0905.
Saved in:
| Title: | 1482O A phase III study comparing methotrexate (M), adriamycin (A) and cisplatin (P) with MAP + ifosfamide (MAP + IF) for the treatment of osteosarcoma: JCOG0905. |
|---|---|
| Authors: | Hiraga, H.1 (AUTHOR), Machida, R.2 (AUTHOR), Kawai, A.3 (AUTHOR), Matsumoto, Y.4 (AUTHOR), Yonemoto, T.5 (AUTHOR), Nishida, Y.6 (AUTHOR), Nagano, A.7 (AUTHOR), Ae, K.8 (AUTHOR), Yoshida, S.9 (AUTHOR), Asanuma, K.10 (AUTHOR), Toguchida, J.11 (AUTHOR), Huruta, D.12 (AUTHOR), Nakayama, R.13 (AUTHOR), Akisue, T.14 (AUTHOR), Hiruma, T.15 (AUTHOR), Morii, T.16 (AUTHOR), Tanaka, K.17 (AUTHOR), Kataoka, T.18 (AUTHOR), Fukuda, H.2 (AUTHOR), Ozaki, T.19 (AUTHOR) |
| Source: | Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1225-S1225. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2022.07.1585 |
